Amaç: Bu araştırmanın amacı, kardiyovasküler hastalığı olan bireylerin serum ferritin quartillerine göre antropometrik ölçümlerini saptamaktır. Gereç ve Yöntemler: Bu araştırma, Ağustos-Ekim 2019 tarihleri arasında yapılmıştır. Araştırma, Gaziantep Dr. Ersin Arslan Eğitim ve Araştırma Hastanesi Endokrinoloji ve Metabolizma Polikliniğine başvuran ve hekim tarafından genel sağlık muayenesi yapılmış, çalışmaya katılmayı gönüllü olarak kabul etmiş, 20-64 yaş arasında 59 (%57,3) erkek ve 44 (%42,7) kadın olmak üzere toplam 103 erişkin birey üzerinde yürütülmüştür. Bireylerin vücut ağırlığı (kg), boy uzunluğu (cm), bel çevresi (cm), kalça çevresi (cm), üst orta kol çevresi (cm) gibi antropometrik ölçümleri alınmıştır. Bireylerin bel/boy ve bel/kalça oranı, beden kitle indeksi (kg/m2) hesaplanmıştır. Bireylerin serum ferritin düzeyleri, küçükten büyüğe doğru sıralanıp %25'lik 4 gruba ayrılarak, quartil (çeyreklik) sınıflamaları yapılmıştır. Bulgular: Erkeklerin yaş ortalaması 52,9±10,15 yıl, kadınların yaş ortalaması ise 51,6±11,71 yıl olup, toplam yaş ortalaması 52,3±10,81 yıl olarak belirlenmiştir. Bireylerin cinsiyete ve ferritin quartillerine göre antropometrik ölçümlerinin ortalama ve alt-üst değerleri incelendiğinde, bel/kalça ve bel/boy oranında her 2 cinsiyette ferritin quartillerine göre istatistiksel olarak anlamlı bir farklılık bulunmamıştır (p>0,05). Bireylerin insülin direnci varlığına göre serum ferritin düzeyleri ve antropometrik ölçümler arasındaki ilişki incelendiğinde, tüm bireylerde bel/kalça oranı ile serum ferritin arasında pozitif bir korelasyon görülmüştür ve istatistiksel olarak anlamlı bulunmuştur (p<0,05). Sonuç: Kardiyometabolik hastalıkların patofizyolojsinde önemli bir biyokimyasal belirteç olan serum ferritin seviyeleri ile antropometrik ölçümlerde, özellikle bel/kalça ve bel/boy oranı kardiyovasküler hastalıklar ve bunlarla ilişkili komplikasyonları önden tahmin etmede güvenilir antropometrik ölçümler olarak halk sağlığında kullanılabilir.
Anahtar Kelimeler: Antropometri; ferritin; metabolik sendrom; kardiyovasküler hastalıklar
Objective: The aim of this study is to determine anthropometric measurements of patients with cardiovascular disease according to serum ferritin quartiles. Material and Methods: This research was conducted between August-October 2019. General health examination was performed by physician who applied to Ersin Arslan Training and Research Hospital Endocrinology and Metabolism Clinic. It was conducted on total of 103 individuals, between 20-64 ages, 59 (%57,3) males and 44 (%42,7) females. Anthropometric measurements such as body weight (kg), height (cm), waist circumference (cm), hip circumference (cm), upper-middle arm circumference (cm) were taken. Waist/height ratio, waist/hip ratio, body mass index (kg/m2) of individuals were calculated. Serum ferritin levels of individuals were classified from small to large and divided into 4 groups of quartiles of 25%. Results: The average age of men was 52.9±10.15 years, 51.6±11.71 years for women, total average age was 52.3±10.81 years. Values of anthropometric measurements according to gender and ferritin quartiles were analyzed and no statistically significant difference was found in waist/hip ratio and waist/height ratio compared to ferritin quartiles in both genders (p>0.05). Relationship between serum ferritin levels and anthropometric measurements according to insulin resistance of individuals was investigated, a positive correlation was found between waist/hip ratio and serum ferritin in all individuals, and it was found statistically significant (p<0.05). Conclusion: Serum ferritin levels, which are important biochemical indicators in pathophysiology of cardiometabolic diseases, within anthropometric measurements, especially waist/hip ratio and waist/height ratio, can be used in public health nutrition as reliable anthropometric measurements to predict cardiovascular diseases and their related complications.
Keywords: Anthropometry; ferritin; metabolic syndrome; cardiovascular diseases
- World Health Organization [İnternet]. © 2022 WHO [Erişim tarihi: 3 Mart 2019]. Cardiovascular disease. Erişim linki: [Link]
- Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254-743. [PubMed]
- Cai X, Zhang Y, Li M, Wu JH, Mai L, Li J, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020; 370:m2297. [Crossref] [PubMed] [PMC]
- Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104(22):2746-53. [Crossref] [PubMed]
- Scott J. Pathophysiology and biochemistry of cardiovascular disease. Curr Opin Genet Dev. 2004;14(3):271-9. [Crossref] [PubMed]
- Francula-Zaninovic S, Nola IA. Management of measurable variable cardiovascular disease' risk factors. Curr Cardiol Rev. 2018; 14(3):153-63. [Crossref] [PubMed] [PMC]
- Kang HT, Linton JA, Shim JY. Serum ferritin level is associated with the prevalence of metabolic syndrome in Korean adults: the 2007-2008 Korean National Health and Nutrition Examination Survey. Clin Chim Acta. 2012;413(5-6):636-41. [Crossref] [PubMed]
- Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed. Philadelphia, PA: Elsevier/ Saunders; 2015.
- Reis AH. On the etiology of cardiovascular diseases: a new framework for understanding literature results. Med Hypotheses. 2016;92: 94-9. [Crossref] [PubMed]
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. [Crossref] [PubMed]
- Consensus Development Conference on Insulin Resistance. 5-6 November 1997. American Diabetes Association. Diabetes Care. 1998;21(2):310-4. [Crossref] [PubMed]
- World Health Organization [İnternet]. © 2022 WHO [Erişim tarihi: 20 Ekim 2019]. WHO BMI Classification. Erişim linki: [Link]
- World Health Organization. Waist Circumference and Waist-Hip Ratio: Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation. Geneva: WHO; 2011. [Link]
- McDowell MA, Fryar CD, Ogden CL, Flegal KM. Anthropometric Reference Data for Children and Adults: United States, 2003-2006. National Health Statistics Reports; 2008. [Crossref]
- IBM SPSS Statistics for Windows. Version 23.0. IBM Corp. Released 2015; 2015. Armonk, NY IBM Corp. [Link]
- Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11): e596-646. [Crossref] [PubMed] [PMC]
- Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275-86. [Crossref] [PubMed]
- Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2019 update: a report from the american heart association. Circulation. 2019;139(10):e56-528. [PubMed]
- Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1): 111-88. [PubMed]
- Wierup I, Carlsson AC, Wändell P, Riserus U, Ärnlöv J, Borné Y. Low anthropometric measures and mortality--results from the Malmo Diet and Cancer Study. Ann Med. 2015; 47(4):325-31. [Crossref] [PubMed]
- Hardy DS, Stallings DT, Garvin JT, Xu H, Racette SB. Best anthropometric discriminators of incident type 2 diabetes among white and black adults: a longitudinal ARIC study. PloS One. 2017;12(1):e0168282. [Crossref] [PubMed] [PMC]
- Carlsson AC, Risérus U, Engström G, Ärnlöv J, Melander O, Leander K, et al. Novel and established anthropometric measures and the prediction of incident cardiovascular disease: a cohort study. Int J Obes (Lond). Dec 2013;37(12):1579-85. [Crossref] [PubMed]
- Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52. [Crossref] [PubMed]
- Zhou FL, Gao Y, Tian L, Yan FF, Chen T, Zhong L, et al. Serum ferritin is associated with carotid atherosclerotic plaques but not intima-media thickness in patients with abnormal glucose metabolism. Clin Chim Acta. 2015;450:190-5. [Crossref] [PubMed]
- Bektaş B, Perim FT. Koroner anjiyografi uygulanacak hastalarda beslenme durumu ile kardiyovasküler risk etmenleri arasındaki ilişkinin değerlendirilmesi [Determination of cardiovascular risk factors and nutritional assessment in patients undergoing coronary angiography]. Bes Diy Derg. 2017;45(2):128-36. [Link]
- Türkiye Cumhuriyeti Sağlık Bakanlığı. Gaziantep Beslenme ve Sağlık Araştırması 2017. Erişim tarihi: 2.05.2019. Erişim linki: [Link]
- Pasdar Y, Moradi S, Moludi J, Saiedi S, Moradinazar M, Hamzeh B, et al. Waist-to-height ratio is a better discriminator of cardiovascular disease than other anthropometric indicators in Kurdish adults. Sci Rep. 2020; 10(1):16228. [Crossref] [PubMed] [PMC]
- Rådholm K, Chalmers J, Ohkuma T, Peters S, Poulter N, Hamet P, et al. Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: results from the ADVANCE-ON study. Diabetes Obes Metab. 2018;20(8):1903-10. [Crossref] [PubMed]
- Rangel-Baltazar E, Cuevas-Nasu L, Shamah-Levy T, Rodríguez-Ramírez S, Méndez-Gómez-Humarán I, Rivera JA. Association between high waist-to-height ratio and cardiovascular risk among adults sampled by the 2016 Half-Way National Health and Nutrition Survey in Mexico (ENSANUT MC 2016). Nutrients. 2019;11(6):1402. [Crossref] [PubMed] [PMC]
- Cho MR, Park JK, Choi WJ, Cho AR, Lee YJ. Serum ferritin level is positively associated with insulin resistance and metabolic syndrome in postmenopausal women: a nationwide population-based study. Maturitas. 2017;103:3-7. [Crossref] [PubMed]
- Chen L, Li Y, Zhang F, Zhang S, Zhou X, Ji L. Association of serum ferritin levels with metabolic syndrome and insulin resistance in a Chinese population. J Diabetes Complications. 2017;31(2):364-8. [Crossref] [PubMed]
- Xu H, Song Y, Xu J, Gu Y, Zhang Q, Liu L, et al. Increased serum ferritin levels are independently associated with carotid atherosclerosis in women. Br J Nutr. 2017;117(11): 1623-30. [Crossref] [PubMed]
- Wang YL, Koh WP, Yuan JM, Pan A. Plasma ferritin, C-reactive protein, and risk of incident type 2 diabetes in Singapore Chinese men and women. Diabetes Res Clin Pract. 2017; 128:109-18. [Crossref] [PubMed]
- Jehn ML, Guallar E, Clark JM, Couper D, Duncan BB, Ballantyne CM, et al. A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 2007; 165(9):1047-54. [Crossref] [PubMed]
- Gao S, Zhao D, Qi Y, Wang M, Zhao F, Sun J, et al. The association between serum ferritin levels and the risk of new-onset type 2 diabetes mellitus: a 10-year follow-up of the Chinese Multi-Provincial Cohort Study. Diabetes Res Clin Pract. 2017;130:154-62. [Crossref] [PubMed]
.: Process List